In previous studies, 99mTc-TF was shown to help distinguish between glioma recurrence and necrosis induced by radio chemotherapy, differentiate low- from high-grade tumor, and assess response to treatment and overall prognosis in glioblastoma patients [22,23]. This evidence concerns the gene TF and glioblastoma.